Skip to main content
TipRanks
Go Ultimate75% OFF

Innovent Biologics (6IB) Q4 2020 Earnings Report

4 Followers

DE:6IB Q4 2020 EPS Results

Actual EPS
-EUR 0.04
Consensus EPS
―
Beat/Miss
―
One Year Ago EPS
-EUR 0.11

DE:6IB Q4 2020 Revenue Results

Actual Revenue
EUR 373.85M
Expected Revenue
―
Beat/Miss
―
YoY Revenue Growth
+318.66%

Earnings Announcement Details

Quarter
Q4 2020
Date
03/29/2021
Time
TBA
Conference Call
Monday, March 29, 2021
DE:6IB Upcoming Earnings

Innovent Biologics's next earnings date is estimated for March 31, 2027, based on past reporting schedules.

Q4 2020 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q4 2020 Earnings Slide Deck

No slide deck is available for this earnings event.

Q4 2020 Earnings Call Summary

No earnings call summary is available for this earnings event.

DE:6IB Earnings History

DE:6IB earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Mar 31, 20272026 (Q4)0.15-0――
Aug 25, 20262026 (Q2)0.060.090.0737.25% (+0.03)
Mar 26, 20262025 (Q4)0.02-0.000.02-105.56% (-0.03)
Aug 27, 20252025 (Q2)0.020.07-0.03312.50% (+0.10)
Mar 26, 20252024 (Q4)-0.030.02-0.08131.69% (+0.10)
Aug 28, 20242024 (Q2)-0.03-0.03-0.01-166.67% (-0.02)
Mar 20, 20242023 (Q4)-0.09-0.08-0.1132.38% (+0.04)
Aug 23, 20232023 (Q2)-0.09-0.01-0.0986.15% (+0.08)
Mar 31, 20232022 (Q4)-0.09-0.11-0.1837.78% (+0.07)
Aug 25, 20222022 (Q2)-0.91-0.09-0.1119.75% (+0.02)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed